Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerMicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysisDownregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-AnalysismiR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.MicroRNA analysis of breast ductal fluid in breast cancer patients.miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.Noncoding RNAs in breast cancer.Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsPTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition.MiR-27b directly targets Rab3D to inhibit the malignant phenotype in colorectal cancer.Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
P2860
Q26775086-3DBE629A-585B-4D64-8A21-97B2F19E9FD8Q33765619-321E44E2-08E9-4451-B337-BA8C9E85FAFFQ36181081-6280A965-4449-4B71-9D7A-44A000F25041Q36191985-DF57CA87-D833-4082-8E44-9F85ECD86FC7Q36222283-8AE2ECF4-7E31-4D21-844A-55C369BAE984Q36249008-3629A894-6A5E-47F9-A997-5B8B7F2BAAC9Q36666943-4EBC652B-2738-4615-83EB-BFF6840A7492Q36734184-9EE7227C-B862-41F9-B30F-9C6A294D2DE4Q36797492-7370B0B4-70E9-4155-A1B9-07816F92B1CEQ36935047-1289D303-D369-4356-93CD-84CA1A0984F9Q40392279-486C88A2-F9AA-4631-8C9B-B165C8CEA93EQ41082524-F4C29B77-2332-4AF0-A302-A14270D2C47FQ41548025-1F7FF964-5150-4FDD-AFEB-CDB9B3421749Q41709626-58850D91-CF79-417E-9DA7-FE1DA71E0074Q50105595-ECC0BF8B-D36C-4723-BCF2-9E7FE579AB1FQ55251624-EC820DBE-0A5B-457A-B800-7BD6CBE6B0BEQ58803658-7C4F50CA-0EC7-45EE-957A-81A680DAD881
P2860
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@ast
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@en
type
label
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@ast
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@en
prefLabel
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@ast
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@en
P2093
P2860
P50
P1476
Tumor tissue microRNA expressi ...... egative breast cancer outcomes
@en
P2093
Ping-Ping Bao
Xingyi Guo
Ying Zheng
Yinghao Su
P2860
P2888
P304
P356
10.1007/S10549-015-3460-X
P407
P577
2015-06-11T00:00:00Z